• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Silo Pharma Inc. (Amendment)

    1/25/24 5:27:04 PM ET
    $SILO
    Apparel
    Consumer Discretionary
    Get the next $SILO alert in real time by email
    SC 13G/A 1 ea192209-13ga2reda_silo.htm AMENDMENT NO. 2 TO SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO § 240.13d-2(b)

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    (AMENDMENT NO. 2)

     

    Silo Pharma, Inc.

     

    (Name of Issuer)

     

    Common Shares, par value $0.0001 per share

     

    (Title of Class of Securities)

     

    (CUSIP Number)

     82711P201

     

    December 31, 2023

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the Rule pursuant to which this Schedule is filed:

     

      ☐ Rule 13d – 1(b)
      ☒ Rule 13d – 1(c)
      ☐ Rule 13d – 1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 82711P201

     

    1.

    NAME OF REPORTING PERSON OR

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    Joseph Reda

    2.

    Check The Appropriate Box if a Member of a Group

    (a) ☐

    (b) ☐

    3. SEC Use Only
    4.

    Citizenship or Place of Organization

    U.S.

    Number of
    Shares
    Beneficially
    Owned By
    Each
    Reporting
    Person With
    5.

    Sole Voting Power

    0

    6.

    Shared Voting Power

    0

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

    0

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person
    0

    10. 

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐

    11. 

    Percent of Class Represented By Amount in Row (9)
    0%(1)

    12. 

    Type of Reporting Person (See Instructions)
    IN

     

    (1)

    Based on 3,108,797 shares of Common Stock outstanding as of November 13, 2023.

     

    -1-

     

     

    CUSIP No. 82711P201

     

    1.

    NAME OF REPORTING PERSON OR

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    Joseph Reda C/F Dustin Russell Reda UTMA/NY

    2.

    Check The Appropriate Box if a Member of a Group

    (a) ☐

    (b) ☐

    3. SEC Use Only
    4.

    Citizenship or Place of Organization

    U.S.

    Number of
    Shares
    Beneficially
    Owned By
    Each
    Reporting
    Person With
    5.

    Sole Voting Power

    0

    6.

    Shared Voting Power

    0

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

    0

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person
    0

    10. 

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)  ☐

    11. 

    Percent of Class Represented By Amount in Row (9)
    0%(1)

    12. 

    Type of Reporting Person (See Instructions)
    OO

     

    (1)

    Based on 3,108,797 shares of Common Stock outstanding as of November 13, 2023.

     

    -2-

     

     

    CUSIP No. 82711P201

     

    1.

    NAME OF REPORTING PERSON OR

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    Joseph Reda C/F Joseph William Reda UTMA/NY

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

    3. SEC Use Only
    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION
    U.S.

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5.

    Sole Voting Power

    0

    6.

    Shared Voting Power

    0

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

    0

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    0

    10. 

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐

    11. 

    Percent of Class Represented By Amount in Row (9)
    0%(1)

    12. 

    Type of Reporting Person (See Instructions)
    OO

     

    (1)

    Based on 3,108,797 shares of Common Stock outstanding as of November 13, 2023.

     

    -3-

     

     

    CUSIP No. 82711P201

     

    1.

    NAME OF REPORTING PERSON OR

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    Joseph Reda C/F Angus Patrick Deeney UTMA/NY

    2.

    Check The Appropriate Box if a Member of a Group

    (a) ☐

    (b) ☐

    3. SEC Use Only
    4.

    Citizenship or Place of Organization

    U.S.

    Number of
    Shares
    Beneficially
    Owned By
    Each
    Reporting
    Person With
    5.

    Sole Voting Power

    0

    6.

    Shared Voting Power

    0

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

    0

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person
    0

    10. 

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐

    11. 

    Percent of Class Represented By Amount in Row (9)
    0%(1)

    12. 

    Type of Reporting Person (See Instructions)
    OO

     

    (1)

    Based on 3,108,797 shares of Common Stock outstanding as of November 13, 2023.

     

    -4-

     

     

    CUSIP No. 82711P201

     

    1.

    NAME OF REPORTING PERSON OR

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    Joseph Reda C/F Claire Estie Deeney UTMA/NY

    2.

    Check The Appropriate Box if a Member of a Group

    (a) ☐

    (b) ☐

    3. SEC Use Only
    4.

    Citizenship or Place of Organization

    U.S.

    Number of
    Shares
    Beneficially
    Owned By
    Each
    Reporting
    Person With
    5.

    Sole Voting Power

    0

    6.

    Shared Voting Power

    0

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

    0

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person
    0

    10. 

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐

    11. 

    Percent of Class Represented By Amount in Row (9)
    0%(1)

    12. 

    Type of Reporting Person (See Instructions)
    OO

     

    (1)

    Based on 3,108,797 shares of Common Stock outstanding as of November 13, 2023.

     

    -5-

     

     

    Item 1(a). Name of Issuer:
       
      Silo Pharma, Inc.
       
    Item 1(b). Address of Issuer’s Principal Executive Offices:
       
      560 Sylvan Avenue, Suite 3160, Englewood Cliffs, NJ 07632
       
    Item 2(a). Name of Person Filing.
       
     

    The statement is filed on behalf of Joseph Reda, Joseph Reda C/F Dustin Russell Reda UTMA/NY (“DRR UTMA”), Joseph Reda C/F Joseph William Reda UTMA/NY (“JWR UTMA”), Joseph Reda C/F Angus Patrick Deeney UTMA/NY (“APD UTMA”), and Joseph Reda C/F Claire Estie Deeney UTMA/NY (“CED UTMA”)(collectively, the “Reporting Persons”).

     

    Mr. Reda is also the custodian of each of DRR UTMA, JWR UTMA, APD UTMA, and CED UTMA and in such capacity each has voting and dispositive power over the securities held by each such entity.

       
    Item 2(b). Address of Principal Business Office or, if None, Residence.
       
     

    The address for Reporting Persons is:

    1324 Manor Circle Pelham, NY 10803

       
    Item 2(c). Citizenship.
     

    U.S.

     

    UTMA, JWR UTMA, APD UTMA, and CED UTMA are each organized under the laws of the State of New York.

       
    Item 2(d). Title of Class of Securities.
       
      Common Shares
       
    Item 2(e). CUSIP Number.
      82711P201
       
    Item 3. Type of Person.
       
      Not applicable.
       
    Item 4. Ownership.
       
     

    The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each of the Reporting Persons hereto, including footnotes, and is incorporated herein by reference for the Reporting Persons. The percentage set forth in Row (11) of the cover page for each of the Reporting Persons are calculated based on 3,108,797 shares of Common Stock outstanding as of November 13, 2023, as disclosed on the Issuer’s Quarterly Report on Form 10-Q for the period ended September 30, 2023.

     

    -6-

     

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
       
      Not applicable.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company.
       
      Not applicable.
       
    Item 8. Identification and Classification of Members of the Group.
       
      Not applicable.
       
    Item 9. Notice of Dissolution of Group.
       
      Not applicable.
       
    Item 10. Certifications.
       
      Not applicable

     

    -7-

     

     

    SIGNATURE PAGE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated:  January 25, 2024   By: /s/ Joseph Reda
        Name: Joseph Reda
         
    Dated:  January 25, 2024   Joseph Reda C/F Dustin Russell Reda UTMA/NY
         
        By: /s/ Joseph Reda
        Name:  Joseph Reda
        Title: Custodian
         
    Dated: January 25, 2024   Joseph Reda C/F Joseph William Reda UTMA/NY
         
        By: /s/ Joseph Reda
        Name: Joseph Reda
        Title: Custodian
         
    Dated: January 25, 2024   Joseph Reda C/F Angus Patrick Deeney UTMA/NY
         
        By: /s/ Joseph Reda
        Name: Joseph Reda
        Title: Custodian
         
    Dated: January 25, 2024   Joseph Reda C/F Claire Estie Deeney UTMA/NY
         
        By: /s/ Joseph Reda
        Name: Joseph Reda
        Title: Custodian

     

    -8-

    Get the next $SILO alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SILO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SILO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Weisblum Eric bought $4,329 worth of shares (10,000 units at $0.43), increasing direct ownership by 5% to 197,932 units (SEC Form 4)

      4 - Silo Pharma, Inc. (0001514183) (Issuer)

      5/28/25 4:30:42 PM ET
      $SILO
      Apparel
      Consumer Discretionary
    • CEO and President Weisblum Eric bought $2,097 worth of shares (2,500 units at $0.84), increasing direct ownership by 1% to 187,932 units (SEC Form 4)

      4 - Silo Pharma, Inc. (0001514183) (Issuer)

      12/16/24 5:00:06 PM ET
      $SILO
      Apparel
      Consumer Discretionary
    • CEO and President Weisblum Eric bought $4,625 worth of shares (5,000 units at $0.93), increasing direct ownership by 3% to 185,432 units (SEC Form 4)

      4 - Silo Pharma, Inc. (0001514183) (Issuer)

      11/22/24 4:16:10 PM ET
      $SILO
      Apparel
      Consumer Discretionary

    $SILO
    SEC Filings

    See more
    • Silo Pharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Silo Pharma, Inc. (0001514183) (Filer)

      7/3/25 4:45:29 PM ET
      $SILO
      Apparel
      Consumer Discretionary
    • Silo Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

      8-K - Silo Pharma, Inc. (0001514183) (Filer)

      5/16/25 4:30:32 PM ET
      $SILO
      Apparel
      Consumer Discretionary
    • SEC Form 424B4 filed by Silo Pharma Inc.

      424B4 - Silo Pharma, Inc. (0001514183) (Filer)

      5/16/25 9:08:42 AM ET
      $SILO
      Apparel
      Consumer Discretionary

    $SILO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Weisblum Eric bought $4,329 worth of shares (10,000 units at $0.43), increasing direct ownership by 5% to 197,932 units (SEC Form 4)

      4 - Silo Pharma, Inc. (0001514183) (Issuer)

      5/28/25 4:30:42 PM ET
      $SILO
      Apparel
      Consumer Discretionary
    • SEC Form 4 filed by Director Linsley Wayne

      4 - Silo Pharma, Inc. (0001514183) (Issuer)

      5/27/25 7:03:42 PM ET
      $SILO
      Apparel
      Consumer Discretionary
    • SEC Form 4 filed by Director Munoz Kevin

      4 - Silo Pharma, Inc. (0001514183) (Issuer)

      5/27/25 7:03:16 PM ET
      $SILO
      Apparel
      Consumer Discretionary

    $SILO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

      Technology Co-Developed by the U.S. Department of Veterans Affairs and Emory University NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has entered into a non-binding letter of intent to form a strategic 50:50 joint venture with Hoth Therapeutics, Inc. (NASDAQ:HOTH) to develop and commercialize a potential treatment for obesity and metabolic disease based on technology Hoth has exclusively licensed from the U.S. Department of Veterans Affairs (VA) that was co-developed by the VA and Emory University. The n

      6/25/25 8:38:00 AM ET
      $HOTH
      $SILO
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Apparel
      Consumer Discretionary
    • Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

      *Hoth Therapeutics and Silo Pharma Launch Joint Venture to Commercialize VA-Invented Obesity Drug Targeting $100B+ Global Market Exclusive License from U.S. Department of Veterans Affairs to Advance GDNF-Based Therapy for Obesity and Fatty Liver Disease NEW YORK, June 25, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH) and Silo Pharma, Inc. (NASDAQ:SILO) today announced the formation of a strategic joint venture to develop and commercialize a first-in-class treatment for obesity and metabolic disease based on technology exclusively licensed from the U.S. Department of Veterans Affairs (VA).

      6/25/25 8:27:00 AM ET
      $HOTH
      $SILO
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Apparel
      Consumer Discretionary
    • Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

      SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that the U.S. Patent and Trademark Office (USPTO) had issued a Notice of Allowance for U.S. Patent Application No. 17/954,858 (titled "Biomarkers for Efficacy of Prophylactic Treatments Against Stress-Induced Affective Disorders") that Silo licenses from Columbia University.  The to-be-issued patent will further strengthen Silo's IP protection for its lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent is expected

      6/11/25 9:00:00 AM ET
      $SILO
      Apparel
      Consumer Discretionary

    $SILO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Silo Pharma Inc.

      SC 13G - Silo Pharma, Inc. (0001514183) (Subject)

      7/26/24 4:17:36 PM ET
      $SILO
      Apparel
      Consumer Discretionary
    • SEC Form SC 13G filed by Silo Pharma Inc.

      SC 13G - Silo Pharma, Inc. (0001514183) (Subject)

      6/13/24 5:08:53 PM ET
      $SILO
      Apparel
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Silo Pharma Inc. (Amendment)

      SC 13G/A - Silo Pharma, Inc. (0001514183) (Subject)

      1/25/24 5:27:04 PM ET
      $SILO
      Apparel
      Consumer Discretionary